期刊文献+

口服伊曲康唑与氟康唑治疗念珠性阴道炎疗效比较 被引量:6

Evaluating the efficacy of the treatments for beaded vaginitis between oral itraconazole and fluconazole
下载PDF
导出
摘要 目的:评价伊曲康唑与氟康唑治疗念珠性阴道炎疗效。方法:采用单盲法随机分组,将129例念珠菌患者分为两组。伊曲康唑组65例,伊曲康唑200mg/d,口服,连服3d;氟康唑组64例,氟康唑150mg/d,口服,连服3d。结果:两组患者的指标无显著性差异,资料具有可比性,伊曲康唑组与氟康唑组治疗后的总有效率分别为95%(62/65)和94%(60/64),两组比较无显著性差异(P>0.05)。不良反应发生情况为伊曲康唑组3例(5%),氟康唑组2例(3%),主要为胃肠道反应。结论:伊曲康唑与氟康唑治疗念珠性阴道炎的疗效、不良反应无显著性差异(P>0.05)。临床疗效确切,使用安全、方便。 Objective: To evaluate the efficacy of treatment for beaded vaginitis between itraconazole and fluconazole. Methods: The single-blind way with randomized groups was taken. 129 patients were divided into two groups: the itraconazole group, 65 cases, with 200 mg oral for 3 days. the fluconazole group, 64 cases, with 150 mg oral for 3 days. Results: there was no statistically significant difference between the indicators of two groups. The data was comp arable. The effective rates in itraconazole group and fluconazole group were respectively 95 percent (62/65) and 94 percent (60/64) (P〉0.05). The incident rate of adverse reactions in itraconazole group was 5 percent (3 cases) and in fluconazole group was 3 percent (2 cases), mainly gastrointestinal reactions. Conclusion: There is no significant difference (P〉0.05) in effectiveness and bad reactions in the treatments for beaded vaginltis bewteen itraconazole and flueonazole. The clinical effectiveness is definite, salt and convenient.
作者 陈育煌
出处 《中国医药导报》 CAS 2009年第14期153-153,156,共2页 China Medical Herald
关键词 伊曲康唑 氟康唑 念珠 阴道炎 Itraconazole Fluconazole Bead Vaginitis
  • 相关文献

参考文献4

二级参考文献26

  • 1刘小平,樊尚荣,李建武.妇科门诊患者外阴阴道念珠菌病的检出率和抗真菌药物敏感性研究[J].中国妇产科临床杂志,2004,5(2):95-98. 被引量:24
  • 2QUEIROZ-Telles F,SILVA N,CARVALHO MM, et al. Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in aids patients [J]. Braz J Infect Dis 2001, 5 (2) :60-66.
  • 3陆忠贤 刘荣娟.伊曲康唑胶囊1日疗法治疗阴道念珠菌病[J].中国新药与临床杂志,1999,18(1):62-62.
  • 4Sojakova M,Liptajova D,Borovsky M,et al.Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia[J].Mycopathologia,2004,157:163-169.
  • 5Favel A,Chastin C,Thomet AL,et al.Evaluation of the E test antifungal susceptibility testing of Candida glabrata[J].Eur J Clin Microbiol Infect Dis,2000,19:146-148.
  • 6Birinci A,Sanic A,Durupinar B.Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test[J].J Chemother,2001,13:43-46.
  • 7Costa M,Passos XS,Miranda AT,et al.Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis[J].MycopathologiaM 2004,157:43-47.
  • 8MF, NICHETTI F, del FAVERO A, MARTINO P, et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenie patients with hemalologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial[J]. Clin Infect Dis, 1999, 28(2) :250-255.
  • 9HAROUSSEAU JL. DEKKER AW, STAMATOULLAS-BASTARD A, et al. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B[J]. Antimicrob Agents Chemother, 2000, 44(7) : 1887-1893.
  • 10MORGENSTERN GR, PRENTICE AG, PRENTICE HG, et al.A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies[J]. Br J Haematol, 1999, 105(4):901-911.

共引文献17

同被引文献37

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部